Published in Rev Port Cardiol on May 01, 2003
[Incidence and prevalence of hypercholesterolemia in Portugal]. Rev Port Cardiol (2003) 0.75
Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: meta-analysis of randomised controlled trials. BMJ (2006) 3.68
Clinical comparability of the new antiepileptic drugs in refractory partial epilepsy: a systematic review and meta-analysis. Epilepsia (2011) 1.58
Is the OSCE a feasible tool to assess competencies in undergraduate medical education? Med Teach (2013) 1.52
Gamma interferon-induced T-cell loss in virulent Mycobacterium avium infection. Infect Immun (2005) 1.21
Biochemical impact of a soccer match - analysis of oxidative stress and muscle damage markers throughout recovery. Clin Biochem (2008) 1.17
Intention-to-treat analysis in clinical trials: principles and practical importance. Rev Port Cardiol (2002) 0.99
Incidence and prevalence of hypercholesterolemia in Portugal: a systematic review. Part I. Rev Port Cardiol (2003) 0.96
Impact of Loughborough Intermittent Shuttle Test versus soccer match on physiological, biochemical and neuromuscular parameters. Eur J Appl Physiol (2009) 0.95
Trypanosoma cruzi-Induced Host Immune System Dysfunction: A Rationale for Parasite Immunosuppressive Factor(s) Encoding Gene Targeting. J Biomed Biotechnol (2001) 0.93
Incidence and prevalence of hypercholesterolemia in Portugal: a systematic review. Part III. Rev Port Cardiol (2003) 0.90
Contribution of CD30/CD153 but not of CD27/CD70, CD134/OX40L, or CD137/4-1BBL to the optimal induction of protective immunity to Mycobacterium avium. J Leukoc Biol (2004) 0.87
Interstitial Granulomatous Dermatitis: A Clinicopathological Study. Am J Dermatopathol (2015) 0.87
The burden of disease attributable to smoking in Portugal. Rev Port Pneumol (2009) 0.85
Apoptosis of peripheral CD4(+) T-lymphocytes in end-stage renal disease patients under hemodialysis and rhEPO therapies. Ren Fail (2011) 0.83
Effect of off-road competitive motocross race on plasma oxidative stress and damage markers. Br J Sports Med (2006) 0.82
Apoptosis and autophagy in breast cancer cells following exemestane treatment. PLoS One (2012) 0.82
Vancomycin-induced linear IgA bullous dermatosis: associations. Dermatol Online J (2016) 0.82
The burden of disease and the cost of illness attributable to alcohol drinking--results of a national study. Alcohol Clin Exp Res (2010) 0.81
Topical gels of etofenamate: in vitro and in vivo evaluation. Pharm Dev Technol (2014) 0.80
Cytotoxicity and genotoxicity of chitooligosaccharides upon lymphocytes. Int J Biol Macromol (2011) 0.79
Relative localizing value of amygdalo-hippocampal MR biometry in temporal lobe epilepsy. Epilepsy Res (2006) 0.79
Steroidal aromatase inhibitors inhibit growth of hormone-dependent breast cancer cells by inducing cell cycle arrest and apoptosis. Apoptosis (2013) 0.78
Diagnostic testing, pre- and post-test probabilities, and their use in clinical practice. Rev Port Cardiol (2004) 0.77
Reversal of neuromuscular blockade with sugammadex in a patient with spinal muscular atrophy type III (Kugelberg-Welander syndrome). J Anesth (2011) 0.76
New steroidal aromatase inhibitors: suppression of estrogen-dependent breast cancer cell proliferation and induction of cell death. BMC Cell Biol (2008) 0.76
Statins for primary and secondary prevention of coronary heart disease. A scientific review. Rev Port Cardiol (2004) 0.76
Statin therapy in the primary and secondary prevention of coronary artery disease in patients with type 2 diabetes. A scientific review. Rev Port Cardiol (2004) 0.76
Drug therapy for chronic heart failure due to left ventricular systolic dysfunction: a review. III. Angiotensin-converting enzyme inhibitors. Rev Port Cardiol (2008) 0.75
Calculation, expression and perception of risk in medicine: implications for clinical decision-making. Rev Port Cardiol (2011) 0.75
Types of clinical studies. II. Cohort studies. Rev Port Cardiol (2005) 0.75
Prevalence of hypercholesterolemia in Portugal and Europe: the same reality? Rev Port Cardiol (2003) 0.75
[Guidelines: unity and balance]. Rev Assoc Med Bras (2009) 0.75
Prevention and screening. Part I: General principles. Rev Port Cardiol (2002) 0.75
Prevention and screening. Part II: Critical appraisal of articles on screening. Rev Port Cardiol (2003) 0.75
[Antidiabetic drugs and in-patient admissions attributable to diabetes in Portugal]. Acta Med Port (2012) 0.75
Q: How should one investigate a chronic cough? Cleve Clin J Med (2011) 0.75
An elderly woman with asthma, eosinophilia, and septic shock. Cleve Clin J Med (2007) 0.75
Can kidney deceased donation systems be optimized? A retrospective assessment of a country performance. Eur J Public Health (2011) 0.75
Costs of illness due to hypeercholesterolemia in Portugal. Rev Port Cardiol (2004) 0.75
Drug therapy for chronic heart failure due to left ventricular systolic dysfunction. II. Diuretics. Rev Port Cardiol (2008) 0.75
Physician alert suggesting alpha-1 antitrypsin deficiency testing in pulmonary function test (PFT) results. COPD (2009) 0.75
Drug class effects: definitions and practical applications. Rev Port Cardiol (2002) 0.75
Basics of methodologic analysis of therapeutic trials. Part II: Importance of the results. Rev Port Cardiol (2002) 0.75
[Clinical effectiveness and economical evaluation of preventive vaccination]. Acta Med Port (2011) 0.75
Burden of disease from hypercholesterolemia in Portugal. Rev Port Cardiol (2004) 0.75
Asymptomatic carotid bruit. Rev Port Cardiol (2005) 0.75
Randomization methods in clinical trials. Rev Port Cardiol (2004) 0.75
Cost-Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine in Children in Portugal. Pediatr Infect Dis J (2017) 0.75
Types of clinical studies. Systematic reviews. Rev Port Cardiol (2006) 0.75
[Off-label prescribing: scientific analysis taking the use of bevacizumab in ophthalmology as an example]. Acta Med Port (2013) 0.75
Basics of methodologic analysis of therapeutic trials. Part III: applicability of the results to the individual patient. Rev Port Cardiol (2002) 0.75
Association of rheumatic diseases with early exit from paid employment in Portugal. Rheumatol Int (2014) 0.75
Basics of methodologic analysis of therapeutic trials. Part I: Validity of the results. Rev Port Cardiol (2002) 0.75
The therapeutic approach to paroxysmal or persistent atrial fibrillation: rhythm control versus rate control. A review. Rev Port Cardiol (2004) 0.75
Types of clinical studies. IV. Clinical trials. Rev Port Cardiol (2005) 0.75
Studies of harm. Clinical applications. Rev Port Cardiol (2005) 0.75
[Smoking cessation: evidence-based recommendations]. Rev Port Cardiol (2002) 0.75